English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/82983
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Rare Variants in Calcium Homeostasis Modulator 1 (CALHM1) Found in Early Onset Alzheimer's Disease Patients Alter Calcium Homeostasis

AuthorsRubio-Moscardo, Fanny; Setó-Salvia, Núria; Pera, Marta; Bosch-Morató, Mònica; Plata, Cristina; Belbin, Olivia; Gené, Gemma; Dols-Icardo, Oriol; Ingelsson, Martin; Helisalmi, Seppo; Soininen, Hilkka; Hiltunen, Mikko; Giedraitis, Vilmantas; Lannfelt, Lars; Frank, Ana; Bullido, María Jesús ; Combarros, Onofre; Sánchez-Juan, Pascual; Boada, Mercè; Tárraga, Lluís; Pastor, Pau; Pérez-Tur, Jordi ; Baquero, Miquel; Molinuevo, José L.; Sánchez-Valle, Raquel; Fuentes-Prior, Pablo; Fortea, Juan; Blesa, Rafael; Muñoz, Francisco J.; Lleó, Alberto; Valverde, Miguel A.; Clarimón, Jordi
Issue Date17-Sep-2013
PublisherPublic Library of Science
CitationPLoS ONE 8(9): e74203 (2013)
AbstractCalcium signaling in the brain is fundamental to the learning and memory process and there is evidence to suggest that its dysfunction is involved in the pathological pathways underlying Alzheimer's disease (AD). Recently, the calcium hypothesis of AD has received support with the identification of the non-selective Ca(2+)-permeable channel CALHM1. A genetic polymorphism (p. P86L) in CALHM1 reduces plasma membrane Ca(2+) permeability and is associated with an earlier age-at-onset of AD. To investigate the role of CALHM1 variants in early-onset AD (EOAD), we sequenced all CALHM1 coding regions in three independent series comprising 284 EOAD patients and 326 controls. Two missense mutations in patients (p.G330D and p.R154H) and one (p.A213T) in a control individual were identified. Calcium imaging analyses revealed that while the mutation found in a control (p.A213T) behaved as wild-type CALHM1 (CALHM1-WT), a complete abolishment of the Ca(2+) influx was associated with the mutations found in EOAD patients (p.G330D and p.R154H). Notably, the previously reported p. P86L mutation was associated with an intermediate Ca(2+) influx between the CALHM1-WT and the p.G330D and p.R154H mutations. Since neither expression of wild-type nor mutant CALHM1 affected amyloid ß-peptide (Aß) production or Aß-mediated cellular toxicity, we conclude that rare genetic variants in CALHM1 lead to Ca(2+) dysregulation and may contribute to the risk of EOAD through a mechanism independent from the classical Aß cascade
Description8 páginas, 3 figuras, 1 tabla.
Publisher version (URL)http://dx.doi.org/10.1371/journal.pone.0074203
URIhttp://hdl.handle.net/10261/82983
DOI10.1371/journal.pone.0074203
E-ISSN1932-6203
Appears in Collections:(CBM) Artículos
(IBV) Artículos
Files in This Item:
File Description SizeFormat 
2013 Plos One 008-e74203.pdf846,25 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.